Navigation Links
Clinical Data Demonstrates That LYSTEDA™ Significantly Reduced Menstrual Blood Loss and Limitations on Social, Leisure and Physical Activities in Women With Cyclic HMB
Date:5/19/2010

A Meaningful Reduction in MBL

To quantify 'meaningful' reduction in MBL in women with HMB after treatment with LYSTEDA, data from 294 women in the study were used in a blinded receiver operating characteristic (ROC) analysis.  MBL was measured in two ways during the study.  One measured the blood loss using a validated alkaline hematin method at baseline and after treatment with LYSTEDA. The second measured a meaningful reduction in MBL using the Menorrhagia Impact Questionnaire (MIQ), a patient-reported outcome instrument previously validated in an HMB population.  Women in this study were asked if the change in their period after treatment was 'meaningful or important' after treatment compared to their prior pretreatment cycles.  After treatment with LYSTEDA, women with HMB perceived an MBL reduction of 36 mL or greater to be meaningful.  

Effect of LYSTEDA Treatment on Social, Leisure and Physical Activities

To measure changes in social, leisure and physical activities in women with HMB treated with LYSTEDA, women (n=294) were randomized (2:2:1) to receive LYSTEDA 1.95 g/day (n=115), LYSTEDA 3.9 g/day (n=112), or placebo (n=67) for up to five days per menstrual period for three cycles.  The MIQ was used to measure changes at baseline and after three treatment menstrual cycles.  The questionnaire contains questions about limitations on social, leisure, physical, or work activities during menstruation, and the woman's perception of the influence of MBL on those measures.  Women receiving either dose of LYSTEDA experienced significant improvements in all measurements from baseline compared with placebo (P <.01 for each dose).  Improvement in all measurements was greater in women receiving high-dose LYSTEDA compared with low-dose LYSTEDA.  Both dosage regimens were
'/>"/>

SOURCE Ferring Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Mpex Pharmaceuticals Presents Positive Phase 2 Clinical Trial Results of Aeroquin(TM) (MP-376) Treatment in Cystic Fibrosis Patients
2. ADMIRE-HF Clinical Trial Published in the Journal of the American College of Cardiology
3. ThromboGenics and BioInvent to Receive EUR10 Million Milestone as Partner Roche Begins New Clinical Study with TB-403
4. Omeros Selects Clinical Candidate for MASP-2 Program With Potential Applicability to Multiple Inflammatory Disorders
5. 3M and CitiusTech to Integrate 3M Healthcare Data Dictionary With CitiusTechs BI-Clinical Healthcare Business Intelligence Framework
6. CrystalGenomics Announces Successful Completion of a Phase I SAD Clinical Trial for CG400549, its Novel Antibiotic Candidate
7. Somanetics Corporation Announces 24 Clinical Abstracts on INVOS System Presented at Annual Pediatric Academic Societies National Conference
8. Protege Encore Clinical Trial Evaluates New Investigational Approach For Individuals Recently Diagnosed With Type 1 Diabetes
9. Novocell Becomes ViaCyte, Inc., as it Accelerates Pre-Clinical Development of a Stem Cell Derived Treatment for Diabetes
10. Stereotaxis Updates Progress on Major Clinical Initiative Related to Electrophysiology (EP) Treatment of Ventricular Tachycardia
11. US HIFU Receives Unanimous Approval to Continue the Clinical Investigation of High Intensity Focused Ultrasound (HIFU) for Treatment of Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... DIEGO , Feb. 26, 2015  Tandem Diabetes ... device company and manufacturer of the t:slim® and t:flex™ ... public offering of 5,250,000 shares of its common stock ... share.  The net proceeds to Tandem from this offering ... discounts and commissions and other estimated offering expenses payable ...
(Date:2/26/2015)... 2015  Mobility Ventures LLC, an AM General Company, ... America (NYSE: BAC ) that will make ... the revolutionary MV-1 - - the world,s first and ... to provide safe and comfortable transportation for all passengers ... to purchase a new MV-1 vehicle at the over ...
(Date:2/26/2015)... , February 26, 2015 ... Outlook 2015: First -In- Class Innovations and Cost ... for Large Cap Pharmaceutical Companies research report to ... According to this Global Pharma US & ... as productivity measurements, divestment of non-core assets result ...
Breaking Medicine Technology:Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 3Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 2Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 3Global Pharma U.S. and EU Outlook 2015 Market Research Report 2Global Pharma U.S. and EU Outlook 2015 Market Research Report 3Global Pharma U.S. and EU Outlook 2015 Market Research Report 4
... Germany, January 18, 2012 Eppendorf AG ... to Bibby Scientific for use e.g. in their TC ... 7,074,367. Eppendorf utilizes the technology in its Eppendorf Mastercycler® ... models. Eppendorf AG, based in Hamburg, Germany, ...
... Takeda Pharmaceutical Company Limited ("Takeda", TSE: ... global workforce and consolidate site operations in order to ... than 70 countries, adapt to changing market conditions and ... as outlined in its 2011-2013 Mid-Range Plan (MRP). ...
Cached Medicine Technology:Takeda Announces Strategic Measures to Achieve Efficiencies for Long-Term Growth 2Takeda Announces Strategic Measures to Achieve Efficiencies for Long-Term Growth 3Takeda Announces Strategic Measures to Achieve Efficiencies for Long-Term Growth 4Takeda Announces Strategic Measures to Achieve Efficiencies for Long-Term Growth 5
(Date:2/28/2015)... California (PRWEB) February 28, 2015 Plugin ... of TransFold Volume 2. A fully customizable transition ... , “TransFold Volume 2 gives users total control over ... Christina Austin, CEO of Pixel Film Studios. “TransFold Volume ... X editor.” , TransFold Volume 2 from Pixel Film ...
(Date:2/28/2015)... My Shiney Hiney® LLC., the renowned brand ... Las Vegas, Nevada for the annual ASD Market Week tradeshow. ... leading consumer-goods tradeshows and My Shiney Hiney will be one ... Shiney Hiney can be found at booth number C1663. , ... at-home personal hygiene brush and cleansing system exclusively created to ...
(Date:2/27/2015)... February 27, 2015 Wireless Analytics, ... services, and one of the founders of ... for Bell Mobility within their CLEAN Platform™ (Communications ... Wireless Analytics’ newly developed Bell Mobility Data ... the Canadian wireless carrier’s business customers. , Wireless ...
(Date:2/27/2015)... Beverly Hills, CA (PRWEB) February 27, 2015 ... was in the air for those suffering from Sjögren’s ... had been discovered by researchers at the University of ... the next phase of research was to develop a ... to precisely detect the presence of new autoantibodies. Researchers ...
(Date:2/27/2015)... MD (PRWEB) February 27, 2015 ... (Meso Foundation) and the National Cancer Institute (NCI) ... Mesothelioma at the National Institutes of Health (NIH), ... one part is dedicated to medical professionals and ... is directed to the general public, including patients, ...
Breaking Medicine News(10 mins):Health News:Announcing a New TransFold Transition Pack from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:My Shiney Hiney® to Participate in ASD Market Week 2015 2Health News:Bell Mobility Gains Traction With Enterprises; Is Added to Wireless Analytics’ CLEAN Platform™ 2Health News:Bell Mobility Gains Traction With Enterprises; Is Added to Wireless Analytics’ CLEAN Platform™ 3Health News:Breakthrough Blood Test for Early Detection of Sjögren’s Syndrome Now Available 2Health News:Conference on Mesothelioma Co-Hosted with National Cancer Institute 2Health News:Conference on Mesothelioma Co-Hosted with National Cancer Institute 3
... (HealthDay News) -- Asthma and chronic obstructive pulmonary disease ... face a significantly higher relative risk for both the ... The warning stems from an analysis of data ... use was associated with a 34 percent increase in ...
... HealthDay Reporter , WEDNESDAY, Dec. 15 (HealthDay News) ... States has declined 28 percent since the late 1990s, but ... deaths, a new study finds. And the cost of ... or any other diagnostic group, an estimated $286 billion in ...
... Reinberg HealthDay Reporter , WEDNESDAY, Dec. 15 (HealthDay News) ... had both leukemia and AIDS no longer has any detectable HIV ... leukemia three years ago. But experts were quick to ... treatment of AIDS worldwide. As it turns out, the ...
... infected at some time in their lives with Epstein-Barr virus ... immune systems, such as people with organ transplants or HIV ... this virus. Scientists at the Duke Cancer Institute have ... EBV infections, a finding that has implications for understanding the ...
... received a 2010 Web Health Award for its patient-geared ... is a national competition that recognizes high-quality electronic health ... competition from a variety of health care professionals nationwide. ... electronic health information experts., This year, ASTRO received a ...
... , WEDNESDAY, Dec. 15 (HealthDay News) -- A group that ... to watch for attempted suicides in patients with no history ... by the Joint Commission, stresses that it,s not just psychiatric ... diagnosed with cancer who goes to an ER because the ...
Cached Medicine News:Health News:Inhalers Linked to Higher Odds of Diabetes in Asthma, COPD Patients 2Health News:Inhalers Linked to Higher Odds of Diabetes in Asthma, COPD Patients 3Health News:Death Rate From Heart Disease, Stroke Drops Off Over Decade 2Health News:Death Rate From Heart Disease, Stroke Drops Off Over Decade 3Health News:Docs Claim Transplant Cured Man of HIV, But Experts Urge Caution 2Health News:Docs Claim Transplant Cured Man of HIV, But Experts Urge Caution 3Health News:Scientists decode secrets of a very common virus that can cause cancer 2Health News:Severe Pain Can Trigger Suicide in Hospital ERs 2Health News:Severe Pain Can Trigger Suicide in Hospital ERs 3
... coded patient identification bracelets (wristbands) and/or ... at patient care areas throughout the ... identification and in creating a positive ... back to the patient through the ...
The IDENTI-PRINT II ID system functions as a complete, hospital wide patient identification system. It integrates the benefits of bedside labeling into a multipurpose ID band that consolidates admitt...
... Volks drive to provide ... to bring you a lens ... in a non-contact slit lamp ... true 3D viewing of the ...
... compact RFID printing solution that can encode ... the R2844-Z printer/encoder is one of the ... printing and encoding smart media such as ... the needs of applications requiring greater processing ...
Medicine Products: